Several analysts, journalists and NextInsight will be in Israel from today (Monday) till Thursday to visit The Trendlines Group.

We will visit the facilities where Trendlines' agricultural portfolio companies operate in the south of Jerusalem. We will also visit the medical-focused portfolio companies and Trendlines' headquarters in the Galilee.

Trendlines Co-Chairmen and Co-CEOs Steve Rhodes and Todd Dollinger will grant us some interview time.

The highlight: the 6th Annual Trendlines Company Showcase, where Trendlines portfolio companies will present their technologies to potential investors and partners from Israel and overseas
 (event details here). 

And thankfully, we will have some time to sight-see Israel, especially certain historic sites. Look out for our report and pictures!

Steve Rhodes 27.11.2015Steve Rhodes, Co-Chairman & Co-CEO of The Trendlines Group.
NextInsight file photo.
Trendlines Group Co-CEO Steve Rhodes was in Singapore just last week (21 Jan 2016) where he hosted an investor briefing organised by NextInsight (open invite was published here).

Among the many interesting technologies being developed by Trendlines' portfolio companies is one that promises to dramatically enhance the quality of life of people who have undergone colostomy.

In that procedure, after a part of the colon has been removed due to a disease such as cancer, one end of the colon is sutured to the side of the abdominal wall and an opening created to allow faecal matter to enter a disposable bag. 

"It's life-saving but it has a huge negative impact on the quality of life. For 65 years, no one has succeeded in coming up with a technology to get rid of the bag until our portfolio company, Stimatix GI, came along," said Mr Rhodes.

The device by Stimatix allows users to regain control of their lives. Photo:
Stimatix has developed a "cap" that sits over the opening in the abdominal wall. "If you see someone wearing it, you'd think it's a bandage as it's skin color and flat."

How it works: "When the person feels pressure building up behind it, he goes to a bathroom, remove the cover and a bag folded up inside comes out. It is removed and disposed of, and a new one is put on."

Stimatix was awarded "Best Start-Up 2011" by Israel’s Office of the Chief Scientist of the Ministry of Economy.

With CE and FDA approval already secured, the device can now be sold in Europe and the US. This year, Stimatix will build up its capability for mass-production and targets to deliver the device to the market in early 2017.

Worldwide, about 1.5 million people use ostomy bags daily. The ostomy care market is worth about US$2 billion annually with three ostomy bag suppliers (ConvaTec, Coloplast, and Hollister) supplying to more than 90% of the market.

Trendlines first invested in Stimatix in 2009 and currently owns a 27.17% stake in it. For more, read this story.

You may also be interested in:

You have no rights to post comments

Counter NameLastChange
AEM Holdings2.740-0.040
Avi-Tech Electronics0.250-0.005
Best World1.790-0.020
Broadway Ind0.0890.005
China Sunsine0.385-0.005
Delfi Limited1.040-0.010
Food Empire1.410-0.040
Fortress Minerals0.260-
Geo Energy Res0.415-
GSS Energy0.029-
Hong Leong Finance2.540-
Hongkong Land (USD)3.3500.090
ISDN Holdings0.3500.005
IX Biopharma0.043-
Jiutian Chemical0.025-0.001
KSH Holdings0.240-
Leader Env0.053-
Medtecs Intl0.140-0.001
Nordic Group0.350-
Oxley Holdings0.092-0.001
REX International0.127-
Sinostar PEC0.140-
Southern Alliance Mining0.580-0.005
Straco Corp.0.510-0.005
Sunpower Group0.210-
The Trendlines0.086-
Totm Technologies0.026-0.001
Uni-Asia Group0.865-0.035
Wilmar Intl3.2800.040
Yangzijiang Shipbldg1.680-0.010

We have 465 guests and no members online

rss_2 NextInsight - Latest News